Evaluation of the Philips Lifeline CareSage Risk Assessment System

NACompletedINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

May 19, 2017

Primary Completion Date

April 16, 2019

Study Completion Date

November 30, 2019

Conditions
Multimorbidity
Interventions
OTHER

Lifeline CareSage Flagging

Patients in the intervention group will receive active monitoring by the CareSage risk assessment platform and clinical interface, including nurse triage calls and tailored PHH interventions. Beginning at month 4, the CareSage algorithm will assess patients' risk for emergency transport every 30 days. Patients identified as high risk will receive nurse triage calls and, depending on their needs, tailored care according to a stepped-care approach. The principal goals will be to reinforce the patients' education, ensure compliance with medications and diet, and identify recurrent symptoms amenable to treatment on an outpatient basis to avoid readmissions

Trial Locations (1)

02451

Partners Healthcare at Home, Waltham

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Philips Healthcare

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT03126565 - Evaluation of the Philips Lifeline CareSage Risk Assessment System | Biotech Hunter | Biotech Hunter